comparemela.com

Latest Breaking News On - Harbour biomed - Page 13 : comparemela.com

HanAll Biopharma Reports Full-Year 2022 Results and Provides Business Update

/PRNewswire/ HanAll Biopharma Co., Ltd. (KRX: 009420. KS), a global biopharmaceutical company committed to discovering and developing innovative medicines.

China
Seoul
Soult-ukpyolsi
South-korea
Japan
Sean-jeong
Hanall-biopharma
Co-ltd
Pipeline-development
Prnewswire-hanall-biopharma-co-ltd
Daewoong-pharmaceutical-co
Devices-agency

HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders

/PRNewswire/ HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced that it.

China
Delaware
United-states
Boston
Massachusetts
Boston-university
Cambridge
Cambridgeshire
United-kingdom
Michael-rosenblatt
Jingsong-wang
Robert-kamen

HBM Alpha Therapeutics Raises Seed Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Boston
Massachusetts
United-states
Cambridge
Cambridgeshire
United-kingdom
Frank-grosveld
Joseph-majzoub
University-of-cambridge
Harbour-biomed
Boston-children
Scientific-advisory-board

Harbour BioMed Announces IND Clearance for First-in-Class Anti-B7H7 Antibody by the U.S. FDA

/PRNewswire/ Harbour BioMed (the"Company", HKEX: 02142) announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug.

China
Cambridge
Cambridgeshire
United-kingdom
Netherlands
Suzhou
Jiangsu
Harbour-biomed-the-company
Drug-administration
Harbour-biomed

Lung Screening Saves Lives; Clues to Hyperprogression; Bacteria Foil Immunotherapy

News, features, and commentary about cancer-related issues

United-states
Philadelphia
Pennsylvania
America
American
Charles-bankhead
Public-health
International-journal-of-environmental-research
Radiological-society-of-north-america
American-cancer-society
Mount-sinai
Radiological-society

vimarsana © 2020. All Rights Reserved.